Paul C Hendrie (Paul Hendrie)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

End Stage Renal Disease

Acute Lymphoblastic Leukemia

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival, Ryan D Cassaday, Vivian G Oehler, Pamela S Becker, Jacob S Appelbaum, Janis L Abkowitz, Johnnie J Orozco, Sioban B Keel, Paul C Hendrie, Bart L Scott, Cristina Maria M Ghiuzeli, Elihu Estey, Roland Bruno Walter
Phase 1/2 Study of Sorafenib Added to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone in Untreated AML. Blood advances (2023)
Miranda C Lahman, Thomas M Schmitt, Kelly G Paulson, Nathalie Vigneron, Denise Buenrostro, Felecia D Wagener, Valentin Voillet, Lauren Martin, Raphaël Gottardo, Jason Bielas, M Juliana McElrath, Derek L Stirewalt, Era L Pogosova-Agadjanyan, Cecilia C S Yeung, Robert H Pierce, Daniel N Egan, Merav Bar, Paul C Hendrie, Sinéad Kinsella, Aesha Vakil, Jonah Butler, Mary Chaffee, Jonathan Linton, Megan S McAfee, Daniel S Hunter, Marie Bleakley, Anthony Rongvaux, Benoit J Van den Eynde, Aude G Chapuis, Philip D Greenberg
Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency. Science translational medicine 14 (631) (2022)
Alexandre V Hirayama, Jordan Gauthier, Kevin Anthony Hay, Jenna M Voutsinas, Qian Wu, Ted Gooley, Daniel Li, Sindhu Cherian, Xueyan Chen, Barbara S Pender, Reed M Hawkins, Aesha Vakil, Rachel N Steinmetz, Utkarsh H Acharya, Ryan D Cassaday, Aude G Chapuis, Tejaswini M Dhawale, Paul C Hendrie, Hans-Peter Kiem, Ryan C Lynch, Jorge Ramos, Mazyar Shadman, Brian G Till, Stanley R Riddell, David G Maloney, Cameron J Turtle
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells. Blood 133 (17) (2019)